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One hundred and twenty-three dual lumen silicone rubber central venous 
catheters were inserted into 101 patients with hematological malignancies 
undergoing intensive treatment. There was a perioperative complication 
rate of 13%. Open and closed techniques for inserting the catheter were 
compared. The operating time needed for introducing the catheter by the 
closed technique (average, 51 minutes) was significantly shorter (p < 
0.001) than the time needed for the open technique (70 minutes), whereas 
complication rates were equal in both techniques. On average, the 
catheters functioned for 149 days. Complications leading to removal were 
observed in 29.3% of patients, most of which were catheter-related 
infections (20.4%). Thromboembolic omplications leading to removal 
were less frequent (4.1%) and appeared significantly earlier (p < 0.001). 
These data indicate that introduction of the catheter by direct puncture of 
the subclavian vein is a quick and safe technique, and that this type of 
catheter is suitable for long-term use, both for infusion and for blood 
sampling. 
The intensive treatment of patients with hematological malig- 
nancies requires a reliable long-term central venous access. 
During the course of therapy, simultaneous infusion of chemo- 
therapeutics, antibiotics, blood products including bone mar- 
row, parenteral nutrients, and fluids is often necessary. Blood 
sampling for monitoring therapy and for bacteriological culture 
is very frequent. 
To meet all these requirements, various types of indwelling 
catheters have been designed. Single [1, 2] and multiple lumen 
[3-6] catheters as well as totally implantable devices with 
subcutaneous access [7] are available. We prefer a dual lumen 
central venous catheter because it facilitates simultaneous 
infusion at a high flow rate [8] in combination with easy access 
to the system. 
Long-term indwelling catheters in these immunocompro- 
raised and, at times, pancytopenic patients often leads to 
catheter-related complications [ 1, 6]. The aim of this study was 
to investigate the technical aspects of the insertion technique 
and the function of the dual lumen catheter. Complication rates 
were also assessed. 
Reprint requests: T. Wiggers, M.D., Department of Surgical Oncol- 
ogy, Dr. Daniel den Hoed Cancer Center, P.O. Box 5201, 3008 AE 
Rotterdam, The Netherlands. 
Material and Methods 
The records of all consecutive patients receiving a dual lumen 
central venous catheter from November, 1984 to January, 1987 
were reviewed. All patients were presented to us by the 
Department of Hematology prior to undergoing intensive anti- 
cancer therapy, often including bone marrow transplantation. 
Seventy-five percent of the patients had acute leukemia (Table 
1); patients were in all stages of their disease. 
In all cases, a Hemed CVAC 4200 14.0 French silicone rubber 
dual lumen catheter (Gish Biomedical Inc., Santa Ana, Califor- 
nia, U.S.A.) was used with an outer diameter of 4.5 ram, each 
lumen having an internal diameter of 1.6 mm. Its length is 
approximately 85 cm and it has a Dacron | cuff to obtain 
subcutaneous fixation and to act as a barrier to microorganisms. 
Ninety-two patients (74.8%) received the catheter as the first 
long-term central venous catheter, 24 (19.5%) as the second, 5 
(4.1%) as the third, and 2 (1.6%) as the fourth catheter. When 
thrombocyte counts were below 45 x 109/1, thrombocyte trans- 
fusions were given. Perioperative antibiotics were not adminis- 
tered. 
All catheters were inserted under strict sterile conditions in 
the operating room, usually under local anesthesia. Most cath- 
eters were introduced through the open method, usually by a 
cut-down of the external jugular vein [9]. In the course of the 
study, this technique was largely replaced by direct puncture of 
the subclavian vein and introduction of the catheter through a 
peel-away sheath [10] (Table 2). All catheters were tunneled, 
placing the Dacron | cuff at the end of the 15-20-cm long 
subcutaneous tunnel. Immediately after the procedure, an x-ray 
was made, to check for the position of the tip of the catheter and 
to rule out pneumothorax. Complications of the procedure were 
noted: bleeding, pneumothorax, or puncture of the brachial 
plexus. Catheters were flushed with a heparin solution (10 ml of 
a 150 IU/ml solution per lumen) after use or, if not in use, at 
least once a week. No systemic anticoagulants were given 
routinely. 
The end point of this study was removal of the catheter or 
death of the patient. Catheters were removed when: (a) they 
were no longer necessary, (b) there were proven thromboem- 
bolic complications--pulmonary embolism, occlusion of the 
vein by thrombus formation (proven by phlebography or per- 
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Table 1. Patient diagnosis. 
Diagnosis No. of catheters 
Acute leukemia 93 
Myelodysplastic syndrome 14 
Non-Hodgkin's lymphoma 7 
Multiple myeloma 3 
Other 6 
Total 123 
Table 2. Introduction technique. 
Technique Vein No. of catheters 
Open (n = 80) External jugular 55 
Internal jugular 16 
Femoral or great saphenous 3 
Other 6 
Closed (n = 43) Subclavian 43 
Total 123 
sistent occlusion of the catheter, in spite of streptokinase 
infusion), or (c) catheter-related infection was strongly suspect- 
ed--signs of (local) infection or sepsis without incrimination of 
any other focus and without response to at least two 48-hour 
long antibiotic regimens or intensive local therapy (Betadine| 
Catheter-related infection was considered proven when: (a) 
fever of 39.5~ or more dropped more than 1.5~ within 24 
hours of catheter emoval or (b) cultures from the tip of the 
catheter were positive in combination with either positive 
cultures from catheter blood or positive cultures from periph- 
eral blood. 
Table 3. Position of tip of catheter. 
Position 
Superior vena cava 
Right atrium 
Innominate vein 
Other 
Total 
t.00 
"Excluding 3catheters inserted inguinally. 
No. of catheters 
(%) 
0.75 
0.50 
0.25 
0.00 
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Time (days) 
Fig. l. Actual duration of catheter function. 
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Counts and averages were the main tools applied for the 
analysis of the data. The actuarial Kaplan-Meier method was 
used to calculate the proportion of functioning catheters as a 0.25 
function of time. Crosstables were generated to look for possi- 
ble relationships between diagnosis, first or consecutive cathe- 
ter, duration of operation, thrombocyte transfusion, periopera- 0.00 
tive complications, insertion technique, location of catheter 
insertion, and position of catheter tip on the one hand and 
duration of catheter function and occurrence of infectious and 
thromboembolic complications on the other hand. 
I 
500 600 700 
Results 
One hundred and twenty-three dual lumen catheters were 
introduced in 101 patients (72 men, 51 women) with a mean age 
of 43 years (range, 15-82 years). Forty-five patients received 
thrombocyte transfusion. Mean duration of all operations was 
63 minutes (standard eviation = 32). The closed technique 
required significantly less time (51 minutes) than the open 
technique (70 minutes) (p < 0.001). 
In 16 insertions (13.0%), there were perioperative complica- 
tions: minor bleeding (n = 13), pneumothorax (n = 2), and 
puncture of the brachial plexus without neurological sequel (n 
= 1). One of the 2 cases of pneumothorax appeared several 
hours after the operation; both cases needed chest tube drain- 
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Fig. 2. Projected uration of catheter function without complications, 
censoring patients who died with a functioning catheter or patients who 
completed treatment and had the catheter removed. 
age. They occurred only in the group with the closed introduc- 
tion technique (43 catheters), giving this complication a 4.6% 
occurrence. 
Over eighty-five percent of the catheters had an optimal 
position of the tip: in the vena cava superior or right atrium 
(Table 3). Mean duration of catheter function was 149 days 
(range, 0-688 days); after 1 year, 10% of all catheters were still 
functioning (Fig. 1). The actuarial probability of complication 
for functioning of the catheter is shown in Fig. 2. It shows that 
the 1-year actuarial probability of catheter emoval due to 
complications i equal to 45%. Eighty-seven catheters (70.7%) 
functioned without associated complications (Table 4). Forty- 
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Table 4. Fate of all catheters. 
Reason for removal No. of catheters (%) 
No removal: Death of patient 45 (36.6) 
No longer necessary 39 (31.7) 
In situ at conclusion of study 3 (2.4) 
Total uncomplicated 87 (70.7) 
Suspected catheter-related infection 25 (20.4) 
Thromboembolic complication 5 (4.1) 
Combination i fection + thromboembolic 3 (2.4) 
Spontaneous dislodgment 3 (2.4) 
Total complicated 36 (29.3) 
Total 123 (100.0) 
Table 5. Duration of catheter function. 
Group of catheters No. of catheters Mean (days) Range (days) 
All catheters 123 149 0-688 
Without complications 87 155 0-635 
With infections 28 175 11-688 
With thrombosis 8 38 8-102 
five patients (36.6%) died during intensive therapy; none of 
these deaths was considered catheter-related. 
Sixteen catheters (13.0%) were removed in the first 31 days 
because of incorrect placement or early complications. In 
29.3%, there were complications leading to removal of the 
catheter (Table 4). Thirty-nine complications were seen in 36 
catheters. Most of these catheters (n = 25) were removed 
because of suspected catheter-related infections, most (n = 23) 
of which only had sepsis. The majority of the infections were 
caused by Staph. epidermis. Thrombotic omplications were as 
follows: Thrombosis of the host vein (n = 4), thrombosis of the 
catheter (n = I), thrombosis plus sepsis (n = 1), infection of the 
subcutaneous tunnel or exit site plus thrombosis of the vein (n 
= 1), and infection of the subcutaneous tunnel or exit site and 
thrombosis of the vein, pulmonary embolisms, and sepsis (n = 
1). Three catheters dislodged spontaneously due to restlessness 
of the patient. In 26 catheters removed for suspected catheter- 
related sepsis, proof of sepsis according to the preset criteria 
was found in 21 (80.8%). Removal of catheters for proven 
thromboembolic complications was done significantly earlier (p 
< 0.001) than removal for other reasons (Table 5). Crosstables 
gave no indications of a relationship between perioperative 
variables and duration of catheter function or late complica- 
tions. 
Discuss ion  
Only a few studies have been published on dual lumen central 
venous catheters [3, 4, 6, 11]. The group of patients tudied here 
is one that is highly compromised, both during the operation 
and after, when intensive treatment is performed associated 
with severe bone marrow depression. This is made apparent by 
the fact that 36.6% of the patients died during catheter follow- 
up. The high percentage of perioperative bleeding is mainly due 
to the condition of the patient. A 4.6% rate of pneumothorax is 
similar to that seen in other publications [12-15]. 
Operating times needed here are similar to those found in 
series for Hickman catheters [16-18]. Our results show the 
advantage of introducing the catheter through direct puncture 
of the subclavian vein when compared to the cut-down tech- 
nique. Both techniques lead to comparable complication rates, 
both perioperative and long-term as well as comparable dura- 
tion of catheter function. In all our patients, we therefore prefer 
the closed technique. We do not consider thrombocytopenia a 
contraindication for the closed technique, provided these pa- 
tients are given thrombocyte transfusions before operation. 
Lately, due to use of image-intensifier x-ray equipment, the 
whole procedure is often performed within 15-30 minutes. 
The duration of catheter function in our study is long when 
compared to other studies of dual lumen catheters [3, 6, 11] or 
to studies of Hickman catheters [1, 2, 18-20]. The large majority 
of catheters (70%) functioned until no longer needed or until the 
patient died. 
Infection remains the greatest diagnostic and therapeutic 
challenge in patients with hematological malignancies [21], even 
more so in those having a central venous catheter [6]. We 
removed 22.8% of the catheters because of suspected catheter- 
related infections. In 80.8% of the cases of true sepsis, the 
sepsis could be proven to be catheter-related. The earliest 
removal for catheter-related infection in our series was after 11 
days, whereas the catheter lasting longest was finally removed 
for suspected catheter-related infection after 688 days. This 
shows that these infections can only rarely be attributed to 
surgical introduction of the catheter, but are very often related 
to the precarious condition of these patients. Rates of catheter 
removal for suspected catheter-related infections range from 
0% to 23% [3, 4, 6, 11] in studies of dual lumen catheters and are 
around 10% [2] in studies of Hickman catheters. Sanders and 
associates [19] found dual lumen and single lumen catheters 
comparable in rates of infection and other complications. The 
variation of rates of removal for suspected catheter-related 
infections in all these studies may be a result of patient 
selection. 
Only a few catheters were removed because of proven 
thromboembolic complications. The real rate of thromboem- 
bolic complications may, however, be higher. We did not 
perform any diagnostic procedures for thrombosis until it was 
expected on clinical grounds. Other studies [22] indicate that 
most cases of catheter-related thrombosis are usually not ap- 
parent clinically. On the other hand, the problem of a primarily 
or secondarily infected catheter thrombus is well known from 
the widely-used single lumen central venous catheters [23, 24]. 
Part of the infectious complications described as being catheter- 
related may, therefore, be primarily thromboembolic complica- 
tions; however, literature on this subject in silicone rubber 
catheters i  rare [25] and inconclusive. This problem is, there- 
fore, under current (prospective) investigation at our institute. 
This evaluation of our experience with this catheter leads us 
to conclude that the dual lumen silicone rubber catheter is a 
reliable central venous catheter that can be introduced rela- 
tively safely and quickly in highly compromised and thrombo- 
cytopenic patients. The closed introduction technique appears 
to be reliable. The duration of catheter function is long, usually 
long enough for intensive treatment for acute leukemia s well 
as for bone marrow transplantation. 
104 World J. Surg. Vol. 14, No. 1, Jan./Feb. 1990 
R~sum~ 
Cent vingt-trois cathfters en caoutchouc silicon6 ~ double 
lumi~re ont 6t6 mis en place afin de traiter 101 patients ayant 
une maladie hfmatologique grave nfcessitant une thfrapeutique 
lourde. Le taux de complications pfri-opfratoires 6tait de 13%. 
L'ftude a compar6 2techniques d'insertion: avec ou sans abord 
direct. La durfe de l'intervention utilisant la technique sans 
abord direct (51 minutes en moyenne) 6tait significativement 
plus courte que celle de la technique avec abord direct (70 
minutes) (17 < 0.001), alors que le taux de complications 6tait 
similaire dans les 2 groupes. Les cathfters ont restfs fonction- 
nels pendant 149 jours en moyenne. Des complications ont 
nfcessit6 l'ablation du cathfter dans 29.3% des cas (infection le 
plus souvent: 20.4%). Ensuite, venaient les complications 
thromboemboliques (4.1%), mais, qui survenaient plus tft dans 
la p6riode postopfratoire (p < 0.001). Nos rfsultats ugg~rent 
que: la technique d'introduction des cathfters par insertion 
directe dans la veine sous-clavi~re est rapide et sore, et ce type 
de cathfter est bien adapt6 ~ l'utilisation de longue durfe, ~ la 
fois pour perfuser et pour prflever. 
Resumen 
Ciento veintrfs catfteres venosos centrales de caucho sili- 
conizado fueron colocados en 101 pacientes con neoplasias 
hematolfgicas malignas ometidos a tratamiento intensivo. La 
tasa de complicaciones perioperatorias fue de 13%. Se efectu6 
la comparacifn entre las tfcnicas de insercifn abierta y cerrada. 
El tiempo operatorio utilizado para la insercifn del catfter 
mediante la tfcnica cerrada (51 minutos en promedio) fur 
significativamente m~is corto (p < 0.001) que el empleado para 
la inserci6n con la tfcnica abierta (70 minutos), en tanto que las 
tasas de complicaciones fueron iguales. En promedio los cat- 
6teres funcionaron durante 149 dias. Se presentaron complica- 
ciones que obligaron a su remocifn en 29.3% de los casos, la 
mayorfa relacionada con infecciones relativas al catfter 
(20.4%). Las complicaciones tromboemb61icas que hicieron 
necesaria la remocifn fueron menos frecuentes (4.1%) e 
hicieron su aparicifn considerablemente m~is pronto (p < 
0.001). Estos datos indican que: la insercifn del catfter por 
puncifn directa de la vena subclavia es un mftodo r~ipido y 
seguro, y este tipo de catfter es adecuado para uso a largo 
plazo, tanto para efectos de la infusifn como de muestreo de 
sangre. 
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